Skip to main content

Table 1 Descriptive measures concerning age and gender of patients, and development of BCVA in different ARMD subtypes following treatment

From: Intravitreal treatment in patients with exudative age-related macular degeneration and visual acuity ≤ 0.05

 

All types of exsudatlve ARMD

Classic lesion

Occult lesion

Subfoveal fluid

Pigment epithelial detachment

Junlus-Kuhnt maculopathy

Number of eyes (n)

74

17

19

11

9

8

Gender (n): male/female

27/47

10/7

6/13

3/8

2/7

3/5

Patient age in years:

 Mean

81.9

79.5

80.6

85.9

83.7

81.9

 Standard deviation

7.6

8.9

8.1

5.5

4.2

5.9

 Median

83.5

83.0

83.0

85.0

84.0

84.0

 Minimum

58.0

58.0

59.0

77.0

76.0

70.0

 Maximum

96.0

91.0

90.0

96.0

91.0

87.0

BCVA at baseline:

decimal

logMAR

decimal

logMAR

decimal

logMAR

decimal

logMAR

decimal

logMAR

decimal

logMAR

 Mean

0.042

1.42

0.039

1.46

0.047

1.34

0.040

1.44

0.042

1.41

0.035

1.54

 Standard deviation

0.130

0.22

0.015

0.26

0.009

0.14

0.014

0.21

0.014

0.21

0.017

0.34

 Median

0.050

1.30

0.050

1.30

0.050

1.30

0.050

1.30

0.050

1.30

0.040

1.40

 Minimum

0.005

1.30

0.005

1.30

0.013

1.30

0.013

1.30

0.013

1.30

0.005

1.30

 Maximum

0.050

2.30

0.050

2.30

0.050

1.90

0.050

1.90

0.050

1.90

0.050

2.30

BCVA at follow-up:

 Mean

0.082

1.27

0.065

1.33

0.138

1.04

0.077

1.26

0.061

1.36

0.029

1.69

 Standard deviation

0.097

0.40

0.057

0.38

0.158

0.38

0.080

0.38

0.058

0.36

0.020

0.44

 Median

0.050

1.30

0.050

1.30

0.050

1.30

0.050

1.30

0.050

1.30

0.030

1.55

 Minimum

0.005

0.15

0.005

0.70

0.025

0.15

0.013

0.50

0.013

0.70

0.005

1.30

 Maximum

0.700

2.30

0.200

2.30

0.700

1.60

0.300

1.90

0.200

1.90

0.050

2.30

Difference of BCVA between baseline and posttherapy:

 Mean

0.040

−0.15

0.026

−0.13

0.091

−0.30

0.038

−0.17

0.019

−0.06

−0.006

0.15

 Standard deviation

0.096

0.36

0.057

0.31

0.157

0.40

0.086

0.28

0.054

0.37

0.012

0.19

 Median

0.000

0.00

0.000

0.00

0.000

0.00

0.015

−0.20

0.000

0.00

−0.005

0.05

 Minimum

−0.040

−1.20

−0.030

−0.90

−0.015

−1.15

−0.037

−1.20

−0.025

−0.60

−0.020

−0.40

 Maximum

0.650

0.70

0.175

0.40

0.650

0.20

0.028

0.60

0.150

0.30

0.010

0.70

Cases (n/%) of BCVA < 0.05 at baseline and > 0.05 at final visit

7/9 %

2/12 %

1/5 %

2/18 %

0/0 %

1/13 %

Cases (n/%) with a decrease of BCVA of > 0.2 logMAR

29/23 %

4/24 %

9/47 %

6/55 %

3/33 %

1/13 %